A nurse is caring for a 68-year-old patient who has been taking clopidogrel (Plavix) 75 mg daily for the past 3 months following a coronary stent placement. The patient is scheduled for an elective cholecystectomy in 2 weeks. What is the most important nursing action regarding the clopidogrel therapy?

Clopidogrel should be stopped 5-7 days before elective surgery to reduce bleeding risk, and the physician must be notified for cardiac risk management. Other options increase bleeding or thrombotic risks.

Core Nursing Explanation Key Concept Analysis: This question tests the critical nursing management of antiplatelet therapy, specifically clopidogrel (Plavix), in a patient scheduled for elective surgery. The core conflict is balancing the risk of stent thrombosis (a life-threatening event if antiplatelet therapy is stopped) against the risk of surgical bleeding. For patients with a drug-eluting stent (DES) or bare-metal stent (BMS), dual antiplatelet therapy (DAPT) is prescribed for a specific duration to prevent stent occlusion. However, for elective non-cardiac surgery, this therapy must be managed carefully.

Answer Rationale: Key Point! The standard guideline is to discontinue clopidogrel 5 to 7 days before elective surgery to allow for sufficient platelet function recovery and minimize intraoperative and postoperative bleeding risk. This decision is not within the nurse's independent scope; the prescribing physician (often a cardiologist or primary care provider) must be notified. The physician will assess the patient's cardiac risk, the urgency of surgery, and may coordinate with the surgeon and anesthesiologist to develop a perioperative plan, which may involve bridging therapy or other precautions. Therefore, the most important nursing action is to initiate the process of holding the medication and ensuring physician communication.

Distractor Analysis:
Watch out for confusion! Option ①: Continuing clopidogrel until surgery significantly increases the risk of uncontrollable surgical bleeding and is contraindicated for elective procedures.
Option ②: Simply reducing the dose is not standard practice. The antiplatelet effect is not linearly dose-dependent in a way that makes this a safe or evidence-based strategy. The bleeding risk remains elevated.
Option ④: Switching to aspirin is also not an independent nursing decision. While aspirin is sometimes continued perioperatively (especially for high cardiac risk), and clopidogrel is held, this strategy must be determined by the physician. Furthermore, abruptly stopping clopidogrel and starting aspirin does not address the need for the prescribed dual therapy or the planned cessation for surgery.

Related Concepts: This scenario highlights the nurse's role in medication reconciliation and patient advocacy. The nurse must understand the indication for the drug, its mechanism of action (irreversible platelet inhibition), and the serious consequences of both continued use (bleeding) and inappropriate discontinuation (stent thrombosis, myocardial infarction). The timing (3 months post-stent) is crucial, as the required duration of DAPT varies by stent type.

Nursing Clinical Practice Guide Clinical Scenario: You are the pre-op nurse for Mr. Johnson, a 68-year-old with a history of coronary artery disease and a stent placed 3 months ago. During your medication review, you note his clopidogrel (Plavix) prescription. His elective laparoscopic cholecystectomy is scheduled for two weeks from today.

Nursing Intervention Strategy: 1. Assessment: Confirm the type of stent (drug-eluting vs. bare-metal) and the original indication for clopidogrel by reviewing the medical record or consulting the cardiology notes. Assess the patient's understanding of why he takes the medication. 2. Action & Communication: Immediately notify both the surgeon and the prescribing physician (e.g., cardiologist or primary care). Document the communication. Do not just document "hold Plavix before surgery" without an order. 3. Patient Education: Once a plan is established by the medical team, educate the patient clearly: "Mr. Johnson, your doctor has advised that you stop taking your Plavix on [specific date] before your surgery to reduce bleeding risks. Do not restart it until your doctor tells you to after the surgery. Call us immediately if you have any chest pain, shortness of breath, or dizziness before your surgery." 4. Monitoring: In the perioperative period, monitor closely for signs of bleeding (e.g., at surgical site, in urine/stool, bruising) and, equally importantly, for signs of acute coronary syndrome (chest pain, diaphoresis, nausea) which could indicate stent thrombosis.

Patient Safety and Precautions: Never assume a patient should stop a critical medication like clopidogrel without a specific, timed order. The risk of stent thrombosis is highest in the first few months after placement but persists. Always use a multidisciplinary team approach for these decisions.
Nursing Procedure & Medication Flow Step-by-Step for Perioperative Antiplatelet Management: 1. Identify high-risk medications during pre-op assessment (clopidogrel, prasugrel, ticagrelor, warfarin, etc.). 2. Check institutional protocols and guidelines for holding times. 3. Communicate findings to the surgeon AND the prescribing specialist. 4. Obtain and clarify the exact written order (e.g., "Hold clopidogrel 7 days prior to procedure"). 5. Provide clear, written instructions to the patient regarding when to stop and when to restart. 6. Document all communications, orders, and patient education thoroughly. 7. Post-operatively, monitor for bleeding complications and reinstitute therapy as ordered, often once hemostasis is secured.
A Word from Your Senior Nurse "Managing medications like clopidogrel in the surgical patient is where your knowledge truly protects your patient. You are the bridge between cardiology and surgery. I've seen cases where a patient self-discontinued their Plavix out of fear of surgery, leading to a heart attack, and cases where it wasn't held, leading to major bleeding. Your proactive assessment and communication are not just 'following orders'—they are actively preventing catastrophic outcomes. On the NCLEX and in practice, always think: 'What is the biggest threat to this patient right now?' In the pre-op phase for this patient, it's the risk of bleeding from the drug interacting with the planned surgery. Your action to hold it and notify the team directly addresses that threat."